Pulmonary blastoma after liver transplant

A case report

Alfredo Tartarone, Giampiero Romano, Rocco Galasso, Mariarosa Coccaro, Aldo Cammarota, Alessandro Sgambato, Annamaria Bochicchio

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There is an increased risk of cancer after organ transplantation mainly due to the immunosuppressive therapy required in these patients. We report a case of biphasic pulmonary blastoma in an adult male who underwent liver transplant for hepatocellular carcinoma in March 1999, followed by immunosuppressive treatment and adjuvant chemotherapy with epirubicin. Disease-free survival lasted 18 months, then a diagnosis of biphasic pulmonary blastoma was made and the patient underwent a lung lobectomy. Five months after surgical resection a recurrence of this rare tumor was recorded and two cycles of cisplatin + etoposide and ifosfamide + etoposide and one cycle of second-line chemotherapy with vinorelbine were administered. The tolerability and the efficacy of this treatment were poor. The patient died less than one year after diagnosis. To our knowledge this is the first reported case of pulmonary blastoma in a transplant patient. Our findings confirm that organ transplant recipients deserve long-term medical surveillance also in the absence of graft complications, and that pulmonary blastoma is an aggressive tumor with a poor prognosis.

Original languageEnglish
Pages (from-to)173-175
Number of pages3
JournalTumori
Volume88
Issue number2
Publication statusPublished - 2002

Fingerprint

Pulmonary Blastoma
Transplants
Liver
Etoposide
Immunosuppressive Agents
Neoplasms
Epirubicin
Ifosfamide
Organ Transplantation
Adjuvant Chemotherapy
Cisplatin
Disease-Free Survival
Hepatocellular Carcinoma
Recurrence
Drug Therapy
Lung
Therapeutics

Keywords

  • Hepatocellular carcinoma
  • Liver transplantation
  • Pulmonary blastoma
  • Risk of cancer

ASJC Scopus subject areas

  • Cancer Research

Cite this

Tartarone, A., Romano, G., Galasso, R., Coccaro, M., Cammarota, A., Sgambato, A., & Bochicchio, A. (2002). Pulmonary blastoma after liver transplant: A case report. Tumori, 88(2), 173-175.

Pulmonary blastoma after liver transplant : A case report. / Tartarone, Alfredo; Romano, Giampiero; Galasso, Rocco; Coccaro, Mariarosa; Cammarota, Aldo; Sgambato, Alessandro; Bochicchio, Annamaria.

In: Tumori, Vol. 88, No. 2, 2002, p. 173-175.

Research output: Contribution to journalArticle

Tartarone, A, Romano, G, Galasso, R, Coccaro, M, Cammarota, A, Sgambato, A & Bochicchio, A 2002, 'Pulmonary blastoma after liver transplant: A case report', Tumori, vol. 88, no. 2, pp. 173-175.
Tartarone A, Romano G, Galasso R, Coccaro M, Cammarota A, Sgambato A et al. Pulmonary blastoma after liver transplant: A case report. Tumori. 2002;88(2):173-175.
Tartarone, Alfredo ; Romano, Giampiero ; Galasso, Rocco ; Coccaro, Mariarosa ; Cammarota, Aldo ; Sgambato, Alessandro ; Bochicchio, Annamaria. / Pulmonary blastoma after liver transplant : A case report. In: Tumori. 2002 ; Vol. 88, No. 2. pp. 173-175.
@article{cd322e638469474fb0d6bdfa96149cf2,
title = "Pulmonary blastoma after liver transplant: A case report",
abstract = "There is an increased risk of cancer after organ transplantation mainly due to the immunosuppressive therapy required in these patients. We report a case of biphasic pulmonary blastoma in an adult male who underwent liver transplant for hepatocellular carcinoma in March 1999, followed by immunosuppressive treatment and adjuvant chemotherapy with epirubicin. Disease-free survival lasted 18 months, then a diagnosis of biphasic pulmonary blastoma was made and the patient underwent a lung lobectomy. Five months after surgical resection a recurrence of this rare tumor was recorded and two cycles of cisplatin + etoposide and ifosfamide + etoposide and one cycle of second-line chemotherapy with vinorelbine were administered. The tolerability and the efficacy of this treatment were poor. The patient died less than one year after diagnosis. To our knowledge this is the first reported case of pulmonary blastoma in a transplant patient. Our findings confirm that organ transplant recipients deserve long-term medical surveillance also in the absence of graft complications, and that pulmonary blastoma is an aggressive tumor with a poor prognosis.",
keywords = "Hepatocellular carcinoma, Liver transplantation, Pulmonary blastoma, Risk of cancer",
author = "Alfredo Tartarone and Giampiero Romano and Rocco Galasso and Mariarosa Coccaro and Aldo Cammarota and Alessandro Sgambato and Annamaria Bochicchio",
year = "2002",
language = "English",
volume = "88",
pages = "173--175",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Pulmonary blastoma after liver transplant

T2 - A case report

AU - Tartarone, Alfredo

AU - Romano, Giampiero

AU - Galasso, Rocco

AU - Coccaro, Mariarosa

AU - Cammarota, Aldo

AU - Sgambato, Alessandro

AU - Bochicchio, Annamaria

PY - 2002

Y1 - 2002

N2 - There is an increased risk of cancer after organ transplantation mainly due to the immunosuppressive therapy required in these patients. We report a case of biphasic pulmonary blastoma in an adult male who underwent liver transplant for hepatocellular carcinoma in March 1999, followed by immunosuppressive treatment and adjuvant chemotherapy with epirubicin. Disease-free survival lasted 18 months, then a diagnosis of biphasic pulmonary blastoma was made and the patient underwent a lung lobectomy. Five months after surgical resection a recurrence of this rare tumor was recorded and two cycles of cisplatin + etoposide and ifosfamide + etoposide and one cycle of second-line chemotherapy with vinorelbine were administered. The tolerability and the efficacy of this treatment were poor. The patient died less than one year after diagnosis. To our knowledge this is the first reported case of pulmonary blastoma in a transplant patient. Our findings confirm that organ transplant recipients deserve long-term medical surveillance also in the absence of graft complications, and that pulmonary blastoma is an aggressive tumor with a poor prognosis.

AB - There is an increased risk of cancer after organ transplantation mainly due to the immunosuppressive therapy required in these patients. We report a case of biphasic pulmonary blastoma in an adult male who underwent liver transplant for hepatocellular carcinoma in March 1999, followed by immunosuppressive treatment and adjuvant chemotherapy with epirubicin. Disease-free survival lasted 18 months, then a diagnosis of biphasic pulmonary blastoma was made and the patient underwent a lung lobectomy. Five months after surgical resection a recurrence of this rare tumor was recorded and two cycles of cisplatin + etoposide and ifosfamide + etoposide and one cycle of second-line chemotherapy with vinorelbine were administered. The tolerability and the efficacy of this treatment were poor. The patient died less than one year after diagnosis. To our knowledge this is the first reported case of pulmonary blastoma in a transplant patient. Our findings confirm that organ transplant recipients deserve long-term medical surveillance also in the absence of graft complications, and that pulmonary blastoma is an aggressive tumor with a poor prognosis.

KW - Hepatocellular carcinoma

KW - Liver transplantation

KW - Pulmonary blastoma

KW - Risk of cancer

UR - http://www.scopus.com/inward/record.url?scp=0036273013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036273013&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 173

EP - 175

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -